Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
Mireia Bachiller, Lorena Pérez-Amill, Anthony M. Battram, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002866-e002866
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma
Roman M. Shapiro, Rizwan Romee
The Lancet (2025) Vol. 405, Iss. 10473, pp. 98-99
Closed Access | Times Cited: 2
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
Alain E. Andrea, Andrada Chiron, Sarah Mallah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
T‐cell exhaustion in CAR‐T‐cell therapy and strategies to overcome it
Xuechen Yin, Lingfeng He, Zhigang Guo
Immunology (2023) Vol. 169, Iss. 4, pp. 400-411
Open Access | Times Cited: 27
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 16
CAR-NK cells in combination therapy against cancer: A potential paradigm
Junping Li, Hong‐Ming Hu, Kai Lian, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27196-e27196
Open Access | Times Cited: 14
Umbilical cord blood: A promising source for allogeneic CAR-T cells
Dian-Dian Liu, Wei-Cong Hong, Kun‐yin Qiu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 7
The application of autologous cancer immunotherapies in the age of memory-NK cells
Gaby D. Lizana‐Vasquez, Madeline Torres‐Lugo, R. Brent Dixon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Region‐Specific CD16+ Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells
Yan Zhang, Zi-En Wang, Yu Lu, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 6
Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations
Beatriz Martín-Antonio, Belén Blanco, África González‐Murillo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Natural killer cell‐related anti‐tumour adoptive cell immunotherapy
Yuwen Qi, Ying Li, Hua Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 5
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma
Guillem Pascual‐Pasto, Brendan McIntyre, Margaret G. Hines, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Engineering CAR T cells for enhanced efficacy and safety
Yiqian Wu, Ziliang Huang, R Harrison, et al.
APL Bioengineering (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 20
New target DDR1: A “double-edged sword” in solid tumors
Yonggang Tian, Feihu Bai, Dekui Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188829-188829
Closed Access | Times Cited: 17
In vivo production of CAR T cell: Opportunities and challenges
Zhiqiang Song, Yitong Zhou, Binbin Wang, et al.
Genes & Diseases (2025), pp. 101612-101612
Open Access
A new sort of cells for CAR T-cell therapies— Isolating CD14–CD127+ T cells for CAR T-cell manufacture
Yan Luo, Yaqing Qie, Martha E. Gadd, et al.
Cytotherapy (2025)
Closed Access
Exploring the Multifunctional Role of Alpha-Fetoprotein in Cancer Progression: Implications for Targeted Therapy in Hepatocellular Carcinoma and Beyond
Hyun Jung Kim, Minji Jang, Eun‐Mi Kim
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4863-4863
Open Access
Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma
Li Zhang, Xiaohuan Peng, Tao Ma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development
Lorena Pérez-Amill, Álex Bataller, Julio Delgado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy
Mohammadsaleh Jahangir, Omid Yazdani, Mohammad Saeed Kahrizi, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors
Abdolreza Esmaeilzadeh, Kaveh Hadiloo, Marjan Jabbari, et al.
Life Sciences (2023) Vol. 337, pp. 122381-122381
Closed Access | Times Cited: 7
A pluripotent road to immunoengineering
Yun Chang, Qing Deng, Xiaoping Bao
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 8, pp. 541-542
Closed Access | Times Cited: 4
Poliovirus receptor–based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma
Changqing Pan, You Zhai, Chen Wang, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 116, Iss. 3, pp. 389-400
Open Access | Times Cited: 4
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
Anthony M. Battram, Aina Oliver‐Caldés, María Suárez‐Lledó, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 207-223
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top